Page last updated: 2024-10-28

hydroxychloroquine and Genital Neoplasms, Female

hydroxychloroquine has been researched along with Genital Neoplasms, Female in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Genital Neoplasms, Female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thimm, MA1
Rositch, AF1
VandenBussche, C1
McDonald, L1
Garonzik Wang, JM1
Levinson, K1

Other Studies

1 other study available for hydroxychloroquine and Genital Neoplasms, Female

ArticleYear
Lower Genital Tract Dysplasia in Female Solid Organ Transplant Recipients.
    Obstetrics and gynecology, 2019, Volume: 134, Issue:2

    Topics: Adult; Early Detection of Cancer; Female; Genital Neoplasms, Female; Humans; Hydroxychloroquine; Inc

2019